Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
(NASDAQ:AGIO), CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 8:00 am PT/11:00 am […]